(Q43041127)

English

Efficacy of interferon monotherapy to 394 consecutive naive cases infected with hepatitis C virus genotype 2a in Japan: therapy efficacy as consequence of tripartite interaction of viral, host and interferon treatment-related factors

scientific article published in December 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Efficacy of interferon monotherapy to 394 consecutive naive cases infected with hepatitis C virus genotype 2a in Japan: therapy efficacy as consequence of tripartite interaction of viral, host and interferon treatment-related factors (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Hepatitis C virus

1 reference

based on heuristic

inferred from title

Hiromitsu Kumada

10

object named as

Hiromitsu Kumada

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Fumitaka Suzuki

2

object named as

Fumitaka Suzuki

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

9

object named as

Kenji Ikeda

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Masahiro Kobayashi

6

object named as

Masahiro Kobayashi

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Yoshiyuki Suzuki

4

object named as

Yoshiyuki Suzuki

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

1

object named as

Norio Akuta

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

8

object named as

Yasuji Arase

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

7

object named as

Satoshi Saitoh

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

5

object named as

Takashi Someya

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

author name string

Akihito Tsubota

3

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

publication date

1 December 2002

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Journal of Hepatology

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

37

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

831-836

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Prognosis of chronic hepatitis C: results of a large, prospective cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900301-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The natural course of chronic hepatitis C: implications for clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900301-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900301-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900301-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk factors of hepatitis C virus-related liver cirrhosis in young adults: positive family history of liver disease and transporter associated with antigen processing 2(TAP2)*0201 Allele

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900301-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900301-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900301-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical significance of intrahepatic hepatitis C virus levels in patients with chronic HCV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900301-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical relevance of hepatitis C virus genotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900301-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900301-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Genotypic analysis of hepatitis C virus in American patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900301-X

7 January 2021

based on heuristic

inferred from DOI database lookup

HCV genotypes in chronic hepatitis C and response to interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900301-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Genotypic subtyping of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900301-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The predictive value of donor liver biopsies for the development of primary nonfunction after orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900301-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900301-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors influencing ribavirin-induced hemolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900301-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Significance of serum hepatitis C virus RNA levels in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900301-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon alfa treatment of HCV RNA carriers with persistently normal transaminase levels: a pilot randomized controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900301-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. Multicenter Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900301-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Better efficacy of a 12-month interferon alfa-2b retreatment in patients with chronic hepatitis C relapsing after a 6-month treatment: a multicenter, controlled, randomized trial. Le Groupe D'étude et De Traitement du Virus De L'hépatite C (Get.Vhc)

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900301-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Prolonged treatment (2 years) with different doses (3 versus 6 MU) of interferon alpha-2b for chronic hepatitis type C. Results of a multicenter randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900301-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of obesity on pharmacokinetics and biologic effect of interferon-alpha in hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900301-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A histopathological study of the effects of 6-month versus 12-month interferon α-2b therapy in chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900301-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900301-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduction in hepatic cytochrome P-450 is correlated to the degree of liver fat content in animal models of steatosis in the absence of inflammation.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900301-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900301-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatic steatosis in chronic hepatitis C virus infection: prevalence and clinical correlation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900301-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Steatosis and chronic hepatitis C: analysis of fibrosis and stellate cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900301-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Steatosis and bile duct damage in chronic hepatitis C: distribution and relationships in a group of Northern Italian patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900301-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative efficacy of interferon alfa in cirrhotic and noncirrhotic patients with non-A, non-B, C hepatitis. Le Groupe Français pour l'Etude du Traitement des Hépatites Chroniques NANB/C

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900301-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical implications of viral quasispecies heterogeneity in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900301-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis C virus genome complexity correlates with response to interferon therapy: a study in French patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900301-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Mutations in nonstructural protein 5A gene and response to interferon in hepatitis C virus genotype 2 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900301-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900301-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The MxA protein levels in whole blood lysates of patients with various viral infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900301-X

7 January 2021

based on heuristic

inferred from DOI database lookup

In vivo and in vitro induction of MxA protein in peripheral blood mononuclear cells from patients chronically infected with hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900301-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Correlation of interferon-induced expression of MxA mRNA in peripheral blood mononuclear cells with the response of patients with chronic active hepatitis C to IFN-alpha therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900301-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Early hepatitis C virus-RNA responses predict interferon treatment outcomes in chronic hepatitis C. The Consensus Interferon Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900301-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantification of the initial decline of serum hepatitis C virus RNA and response to interferon alfa

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900301-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0168-8278(02)00301-X

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43041127&oldid=2047684656"